Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase Ib Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of Oral PTH (1-34) Formulations in Healthy Subjects

NCT02571140 is registered in ClinicalTrials.gov with Entera Bio Ltd. as lead sponsor.

NCT NCT02571140
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02571140 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase Ib Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of Oral PTH (1-34) Formulations in Healthy Subjects
Lead sponsor
Entera Bio Ltd.
Phase
Phase 1
Overall status
Completed
Start date
October 31, 2013
Completion date
October 31, 2017
Enrollment
30 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

drug safety and bioavailability